Stock 2INV 2INVEST AG
Add to a list
To use this feature you must be a member
Log inSign up

Highlights 2invest AG

Equities

2INV

DE000A3H3L44

Investment Holding Companies

Market Closed - Xetra
Other stock markets
 11:36:23 2024-12-11 am EST 		After market 12:36:28 pm
11.80 EUR +0.85% Intraday chart for 2invest AG 11.70 -0.85%
Aug. 05 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2024 CI
Jul. 29 Elevage Medical Technologies and M&G Investment Management Limited signed term sheet to acquire an 15% stake in 4basebio PLC from entities belonging to Deutsche Balaton AG, certain management and directors of 4basebio and 2invest AG for £29.39 million. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
2invest AG Reports Earnings Results for the Half Year Ended June 30, 2024
Aug. 04
 CI
Elevage Medical Technologies and M&G Investment Management Limited signed term sheet to acquire an 15% stake in 4basebio PLC from entities belonging to Deutsche Balaton AG, certain management and directors of 4basebio and 2invest AG for £29.39 million.
Jul. 28
 CI
2invest AG Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 23
 CI
2invest AG Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-16
 CI
2invest AG Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-05
 CI
2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-10
 CI
2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-20
 CI
2Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021
21-09-24
 CI
Reverse Split: 1 of 9
21-02-28
 FA
4Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020
21-02-10
 CI
Spin off
21-02-02
 FA
4basebio AG cancelled the acquisition of KROMI Logistik AG.
21-01-19
 CI
4basebio AG completed the spin-off of Genomics and DNA manufacturing business.
20-12-07
 CI
4Basebio Ag Reports Earnings Results for the Nine Months Ended September 30, 2020
20-11-19
 CI
The Board of Directors of 4basebio AG announced the spin-off of unknown majority stake in Genomics and DNA manufacturing business.
20-08-16
 CI
4basebio AG Reaffirms Earnings Guidance for the Full Year of 2020
20-08-13
 CI
4Basebio Ag Reports Earnings Results for the Second Quarter Ended June 30, 2020
20-08-13
 CI
Sparta AG (DB:SPT6) made an offer to acquire remaining 95.8% stake in 4basebio AG for €92.3 million.
20-07-26
 CI
4basebio AG Reaffirms Earning Guidance for the Fiscal Year 2020
20-05-14
 CI
Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
20-05-13
 CI
4Basebio Ag Reports Earnings Results for the Full Year Ended December 31, 2019
20-04-24
 CI
Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
20-04-23
 CI
4basebio AG Provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection
20-04-22
 CI
4basebio AG's Equity Buyback announced on December 19, 2019, has closed with 5,584,558 shares, representing 10% for €9.7 million.
20-02-20
 CI
Abcam plc completed the acquisition of TGR Biosciences Pty Ltd, Innova Biosciences Ltd. and Expedeon Ltd. from Expedeon AG.
19-12-31
 CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2INV Stock
  4. News 2invest AG
  5. Highlights